REGENERX BIOPHARMACEUTICALS INC: key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2022)
- $76.8K
- Net Income/Loss (FY2022)
- -$1.7M
- Total Assets (FY2022)
- $382.2K
- Total Equity (FY2022)
- -$3.4M
- Cash Flows from Operating Activities (FY2022)
- -$940.7K
Source: REGENERX BIOPHARMACEUTICALS INC 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
